Company: SMNR
Filing Date: 2025-08-22
Form Type: DEFA14A
Source: 0001213900-25-079507
Chunk: 6

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-22
Form: DEFA14A
Chunk 6
---
|:--------|:----|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 104     |     | Cover Page Interactive Data File (embedded within the                                                                                                                  
 Inline XBRL document).                                                                                                                                                 |

*Certain schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The registrant agrees to furnish a copy of all omitted schedules to the SEC upon its request.

<div align='center'>3

SIGNATURE</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

| Date: August 21, 2025 | DENALI CAPITAL ACQUISITION CORP. 
 By:                              | /s/ Lei Huang           |
|:----------------------|:---------------------------------|:------------------------|
|                       | Name:                            | Lei Huang               |
|                       | Title:                           | Chief Executive Officer |

<div align='center'>4</div>

Exhibit 10.1

Execution Version

<div align='center'>SECURITIES PURCHASE AGREEMENT</div>

SECURITIES PURCHASE AGREEMENT(this “ Agreement”), dated as of August __, 2025, by and among Semnur Pharmaceuticals, Inc., a Delaware corporation, with headquarters located at 960 San Antonio Road, Palo Alto, CA 94303 (“ Semnur”), Denali Capital Acquisition Corp., a Cayman Islands exempted company, with headquarters located at 437 Madison Avenue, 27th Floor, New York, NY 10022 (“ Denali”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “ Buyer” and collectively, the “ Buyers”).

<div align='center'>RECITALS</div>

1. On August 30, 2024, Semnur, Denali and Denali Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Denali (“ Merger Sub”), entered into an Agreement and Plan of Merger, which was amended pursuant to Amendment No. 1 to Agreement and Plan of Merger, dated as of April 16, 2025, and Amendment No. 2 to Agreement and Plan of Merger, dated as of July 22, 2025 (as amended, and as may be further amended from time to time, the “ Merger Agreement”).

2. Pursuant to the Merger Agreement, subject to the terms